The Middle East & Africa acne medication market was valued at US$ 415.25 million in 2022 and is expected to reach US$ 548.39 million by 2030; it is estimated to register at a CAGR of 3.6% from 2023 to 2030.
As individuals seek ways to mitigate the physical and emotional burden associated with severe acne, there is a corresponding increase in the demand for advanced and more effective prescription and over-the-counter treatments. This trend prompts pharmaceutical companies to focus on developing innovative formulations, including topical retinoids, oral antibiotics, hormonal therapies, and advanced topical treatments, to address the complex needs of individuals with severe acne. The increasing prevalence of severe acne and an upsurge in associated costs to economies bolster the Middle East & Africa acne medication market growth.
The acne medication market in this country is driven by a rise in research & development activities, including pharmaceutical and skin care products, along with the flourishing healthcare infrastructure. The government of South Africa is promoting and offering several incentives for domestic manufacturing of drugs; these initiatives have the potential to boost the overall market growth in this country.
Increasing Prevalence of Severe Acne Bolsters Middle East & Africa Acne Medication Market
Severe acne, often characterized by painful cysts, nodules, and persistent inflammation, presents a considerable challenge that can significantly impact people's quality of life. As per the 2022 GBD research, acne has a prevalence rate of 9.4%, ranking it eighth among the most common diseases in the world. Acne vulgaris affects over 85% of young individuals from the age group of 12-25. Such a high prevalence has led to an upsurge in the demand for effective acne medications tailored to address moderate to severe forms of the condition.As individuals seek ways to mitigate the physical and emotional burden associated with severe acne, there is a corresponding increase in the demand for advanced and more effective prescription and over-the-counter treatments. This trend prompts pharmaceutical companies to focus on developing innovative formulations, including topical retinoids, oral antibiotics, hormonal therapies, and advanced topical treatments, to address the complex needs of individuals with severe acne. The increasing prevalence of severe acne and an upsurge in associated costs to economies bolster the Middle East & Africa acne medication market growth.
Middle East & Africa Acne Medication Market Overview
The Middle East & Africa acne medication market is further segmented into the UAE, Saudi Arabia, and South Africa. The market growth in this region can be associated with the huge population base, a surge in demand for pharmaceutical products, and the growing number of research studies being conducted in major countries. South Africa is one of the fastest-growing countries in the Middle East & Africa.The acne medication market in this country is driven by a rise in research & development activities, including pharmaceutical and skin care products, along with the flourishing healthcare infrastructure. The government of South Africa is promoting and offering several incentives for domestic manufacturing of drugs; these initiatives have the potential to boost the overall market growth in this country.
Middle East & Africa Acne Medication Market Segmentation
- The Middle East & Africa acne medication market is segmented based on therapeutic class, formulation, type, acne type, distribution channel, and country.
- Based on therapeutic class, the Middle East & Africa acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held the largest share in 2022.
- In terms of formulation, the Middle East & Africa acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held a larger largest share in 2022.
- By type, the Middle East & Africa acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger largest share in 2022.
- Based on acne type, the Middle East & Africa acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held a larger share in 2022.
- In terms of distribution channel, the Middle East & Africa acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held the largest share in 2022.
- Based on country, the Middle East & Africa acne medication market is categorized into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa acne medication market in 2022.
- Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Galderma SA, Pfizer Inc, GSK Plc, and Viatris Inc are some of the leading companies operating in the Middle East & Africa acne medication market.
Market Highlights
- Based on therapeutic class, the Middle East & Africa acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held 33.5% share of the Middle East & Africa acne medication market in 2022, amassing US$ 139.09 million. It is projected to garner US$ 201.78 million by 2030 to expand at 4.8% CAGR during 2022-2030.
- In terms of formulation, the Middle East & Africa acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held 68.4% share of the Middle East & Africa acne medication market in 2022, amassing US$ 283.97 million. It is estimated to garner US$ 387.82 million by 2030 to expand at 4.0% CAGR during 2022-2030.
- The prescription medicine segment held 65.2% share of Middle East & Africa acne medication market in 2022, amassing US$ 270.56 million. It is predicted to garner US$ 368.58 million by 2030 to expand at 4.0% CAGR during 2022-2030.
- The inflammatory acne segment held 54.7% share of the Middle East & Africa acne medication market in 2022, amassing US$ 227.15 million. It is projected to garner US$ 305.66 million by 2030 to expand at 3.8% CAGR during 2022-2030.
- In terms of distribution channel, the Middle East & Africa acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held 49.6% share of the Middle East & Africa acne medication market in 2022, amassing US$ 206.07 million. It is estimated to garner US$ 287.53 million by 2030 to expand at 4.3% CAGR during 2022-2030.
- Saudi Arabia held 32.4% share of Middle East & Africa acne medication market in 2022, amassing US$ 134.71 million. It is projected to garner US$ 189.58 million by 2030 to expand at 4.4% CAGR during 2022-2030.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa acne medication market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa acne medication market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Middle East & Africa Acne Medication Market Landscape
5. Middle East & Africa Acne Medication Market - Key Market Dynamics
7. Middle East & Africa Acne Medication Market Analysis - by Therapeutic Class
8. Middle East & Africa Acne Medication Market Analysis - by Formulation
9. Middle East & Africa Acne Medication Market Analysis - by Type
10. Middle East & Africa Acne Medication Market Analysis - by Acne Type
11. Middle East & Africa Acne Medication Market Analysis - by Distribution Channel
12. Middle East & Africa Acne Medication Market - Country Analysis
13. Acne Medication Market- Industry Landscape
14. Company Profiles
15. Appendix
List of Tables
List of Figures
Companies Mentioned
Some of the leading companies in the Middle East and Africa Acne Medication market include:- Teva Pharmaceutical Industries Ltd
- Almirall SA
- Johnson & Johnson
- Sun Pharmaceutical Industries Ltd
- Bausch Health Companies Inc
- Galderma SA
- Pfizer Inc
- GSK Plc
- Viatris Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 115 |
| Published | August 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 415.25 Million |
| Forecasted Market Value ( USD | $ 548.39 Million |
| Compound Annual Growth Rate | 3.6% |
| Regions Covered | Africa, Middle East |
| No. of Companies Mentioned | 10 |
